Cargando…
Circulating miR-184 is a potential predictive biomarker of cardiac damage in Anderson–Fabry disease
Enzyme replacement therapy (ERT) is a mainstay of treatment for Anderson–Fabry disease (AFD), a pathology with negative effects on the heart and kidneys. However, no reliable biomarkers are available to monitor its efficacy. Therefore, we tested a panel of four microRNAs linked with cardiac and rena...
Autores principales: | Salamon, Irene, Biagini, Elena, Kunderfranco, Paolo, Roncarati, Roberta, Ferracin, Manuela, Taglieri, Nevio, Nardi, Elena, Laprovitera, Noemi, Tomasi, Luciana, Santostefano, Marisa, Ditaranto, Raffaello, Vitale, Giovanni, Cavarretta, Elena, Pisani, Antonio, Riccio, Eleonora, Aiello, Valeria, Capelli, Irene, La Manna, Gaetano, Galiè, Nazzareno, Spinelli, Letizia, Condorelli, Gianluigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665928/ https://www.ncbi.nlm.nih.gov/pubmed/34897278 http://dx.doi.org/10.1038/s41419-021-04438-5 |
Ejemplares similares
-
Electrocardiogram analysis in Anderson-Fabry disease: a valuable tool for progressive phenotypic expression tracking
por: Parisi, V., et al.
Publicado: (2023) -
Biomarkers in Anderson–Fabry Disease
por: Simonetta, Irene, et al.
Publicado: (2020) -
Kidney Transplant in Fabry Disease: A Revision of the Literature
por: Capelli, Irene, et al.
Publicado: (2020) -
Pathologic substrate of gastropathy in Anderson-Fabry disease
por: Di Toro, Alessandro, et al.
Publicado: (2020) -
Pediatric Restrictive Cardiomyopathies
por: Ditaranto, Raffaello, et al.
Publicado: (2022)